Platelet Function in Patients With an Acute Coronary Syndrome (ATLANTIS-ACS)

Medical University of Vienna

Status: Unknown

Conditions: Acute Coronary Syndrome (ACS)

Study type: Observational

Funder types: Other

Identifiers

NCT01992484

ATLANTIS-ACS

Details and patient eligibility

About

The aims of the study are to:

• explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome
• investigate whether a therapeutic window exist for novel platelet inhibitors
• investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario
• investigate the association between genetic polymorphisms, inflammation, platelet reactivity and clinical outcome
• investigate synergistic effects between aspirin and novel platelet inhibitors

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent
• Acute coronary syndrome at admission
• Planned treatment with novel platelet inhibitors
• Age >18

Exclusion criteria

* Participation in interventional trials